Zielinska et al. showed a significant decrease in SOD activity in patients with IBD compared to the control group, while also noting a significant decrease in glutathione peroxidase (GPX) only in patients with CD [144]. This evidence concerns the gene SOD1 and inflammatory bowel disease.